DK1007088T3 - Rekombinant svine-adenovirusvektor - Google Patents

Rekombinant svine-adenovirusvektor

Info

Publication number: DK1007088T3
Authority: DK; Denmark
Prior art keywords: recombinant; adenovirus vector; recombinant swine; nucleotide sequence; methods
Prior art date: 1997-08-14

Application number

DK98938527T

Other languages

English (en)

Inventor

Michael Anthony Johnson

Jeffrey Michael Hammond

Original Assignee

Commw Scient Ind Res Org

Pig Res Dev Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-14

Filing date

1998-08-14

Publication date

2007-06-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3802849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1007088(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-14 Application filed by Commw Scient Ind Res Org, Pig Res Dev Corp filed Critical Commw Scient Ind Res Org

2007-06-04 Application granted granted Critical

2007-06-04 Publication of DK1007088T3 publication Critical patent/DK1007088T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Plant Pathology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK98938527T 1997-08-14 1998-08-14 Rekombinant svine-adenovirusvektor DK1007088T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPO8560A AUPO856097A0 (en)	1997-08-14	1997-08-14	Vector
PCT/AU1998/000648 WO1999008706A1 (en)	1997-08-14	1998-08-14	Recombinant porcine adenovirus vector

Publications (1)

Publication Number	Publication Date
DK1007088T3 true DK1007088T3 (da)	2007-06-04

Family

ID=3802849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98938527T DK1007088T3 (da)	1997-08-14	1998-08-14	Rekombinant svine-adenovirusvektor

Country Status (17)

Country	Link
US (3)	US7323177B1 (da)
EP (2)	EP1007088B1 (da)
JP (2)	JP4365023B2 (da)
KR (1)	KR100746524B1 (da)
CN (1)	CN100366292C (da)
AT (1)	ATE357250T1 (da)
AU (2)	AUPO856097A0 (da)
BR (1)	BR9811184A (da)
CY (1)	CY1106565T1 (da)
DE (1)	DE69837390T2 (da)
DK (1)	DK1007088T3 (da)
ES (1)	ES2283068T3 (da)
ID (1)	ID24174A (da)
MX (1)	MXPA00001562A (da)
NZ (1)	NZ503039A (da)
PT (1)	PT1007088E (da)
WO (1)	WO1999008706A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO856097A0 (en)	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en)	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
CA2413265A1 (en) *	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
WO2002031168A2 (en) *	2000-10-10	2002-04-18	Genstar Therapeutics	Minimal adenoviral vector and recombinant vaccines based thereon
MXPA03008810A (es)	2001-03-27	2004-02-17	Univ Saskatchewan	Metodos para cultivar circovirus.
WO2003013598A2 (en) *	2001-08-09	2003-02-20	Lam Dominic M K	Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
US7045335B2 (en)	2001-09-06	2006-05-16	Alphavax, Inc.	Alphavirus replicon vector systems
JP3949520B2 (ja) *	2001-09-20	2007-07-25	独立行政法人科学技術振興機構	レギュカルチン過剰発現モデル動物
US7569217B2 (en)	2001-09-24	2009-08-04	University Of Saskatchewan	Porcine adenovirus E1 and E4 regions
KR20030054139A (ko) *	2001-12-24	2003-07-02	학교법인 건국대학교	돼지 오제스키병 바이러스의 ｇＤ 유전자를 포함하는재조합 발현 벡터 및 이를 이용한 ＤＮＡ 백신
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
JP5079981B2 (ja)	2002-12-13	2012-11-21	アルファバックス，インコーポレイティド	アルファウイルス粒子及び調製方法
EP1585812B1 (en)	2002-12-13	2017-01-18	Alphavax, Inc.	Multi-antigenic alphavirus replicon particles and methods
KR101518309B1 (ko)	2003-03-20	2015-05-08	알파벡스, 인크.	개선된 알파바이러스 레플리콘 및 헬퍼 구축물
EP1651666B1 (en)	2003-07-11	2009-05-27	Alphavax, Inc.	Alphavirus-based cytomegalovirus vaccines
ES2321212T3 (es)	2004-05-18	2009-06-03	Alphavax, Inc.	Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
DK1926496T3 (da) *	2005-09-09	2013-09-30	Intervet Int Bv	PCV-2-vaccine
US8163544B2 (en)	2006-07-28	2012-04-24	Commonwealth Scientific And Industrial Research Organisation	Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
DK2183368T3 (da)	2007-06-21	2016-09-05	Alphavax Inc	Promoterfrie kassetter til ekspression af alphavirusstrukturproteiner
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
US20110135688A1 (en) *	2009-12-04	2011-06-09	Michael Sheppard	Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors
KR102012109B1 (ko) *	2012-05-17	2019-08-19	조에티스 엘엘씨	이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
IL247301B (en) *	2014-02-20	2022-07-01	Vaxart Inc	Formulations for small intestinal delivery
EP3307239B1 (en)	2015-06-12	2020-09-16	Vaxart, Inc.	Formulations for small intestinal delivery of rsv and norovirus antigens
CA3047294A1 (en)	2016-12-14	2018-06-21	Zoetis Services Llc	Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CN110904127B (zh) *	2018-09-18	2024-09-20	瓦赫宁恩研究基金会	非洲猪瘟病毒疫苗
WO2022155500A1 (en)	2021-01-14	2022-07-21	Senti Biosciences, Inc.	Secretable payload regulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320068C1 (de)	1993-06-17	1994-12-15	Audi Ag	Verfahren und Vorrichtung zur Reparatur von Fahrzeugkarosserien aus Leichtmetallteilen
CN1115414C (zh) *	1993-07-13	2003-07-23	罗纳-布朗克罗莱尔股份有限公司	用于基因治疗的病毒载体
EP0770157A4 (en)	1994-07-14	1998-01-07	Union Camp Patent Holding	IMPROVED BLEACHING OF A VERY CONCENTRATED LIGNOCELLULOSIC PASTE
FR2725213B1 (fr)	1994-10-04	1996-11-08	Rhone Poulenc Rorer Sa	Vecteurs viraux et utilisation en therapie genique
ES2105984B1 (es) *	1995-11-30	1998-04-16	Iberica Cyanamid	Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en)	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome

1997
- 1997-08-14 AU AUPO8560A patent/AUPO856097A0/en not_active Abandoned
1998
- 1998-08-14 DE DE69837390T patent/DE69837390T2/de not_active Expired - Lifetime
- 1998-08-14 JP JP2000509443A patent/JP4365023B2/ja not_active Expired - Fee Related
- 1998-08-14 US US09/485,512 patent/US7323177B1/en not_active Expired - Fee Related
- 1998-08-14 NZ NZ503039A patent/NZ503039A/xx not_active IP Right Cessation
- 1998-08-14 KR KR1020007001486A patent/KR100746524B1/ko not_active Expired - Fee Related
- 1998-08-14 ES ES98938527T patent/ES2283068T3/es not_active Expired - Lifetime
- 1998-08-14 CN CNB98809116XA patent/CN100366292C/zh not_active Expired - Fee Related
- 1998-08-14 EP EP98938527A patent/EP1007088B1/en not_active Expired - Lifetime
- 1998-08-14 BR BR9811184-1A patent/BR9811184A/pt not_active IP Right Cessation
- 1998-08-14 ID IDW20000491A patent/ID24174A/id unknown
- 1998-08-14 EP EP07005454A patent/EP1825863A1/en not_active Withdrawn
- 1998-08-14 DK DK98938527T patent/DK1007088T3/da active
- 1998-08-14 AT AT98938527T patent/ATE357250T1/de active
- 1998-08-14 WO PCT/AU1998/000648 patent/WO1999008706A1/en not_active Ceased
- 1998-08-14 MX MXPA00001562A patent/MXPA00001562A/es active IP Right Grant
- 1998-08-14 PT PT98938527T patent/PT1007088E/pt unknown
2006
- 2006-03-22 US US11/387,026 patent/US7473428B2/en not_active Expired - Fee Related
2007
- 2007-05-07 CY CY20071100603T patent/CY1106565T1/el unknown
2008
- 2008-08-22 US US12/197,056 patent/US7785602B2/en not_active Expired - Fee Related
2009
- 2009-07-01 JP JP2009156467A patent/JP2009213495A/ja active Pending
2011
- 2011-09-09 AU AU2011224111A patent/AU2011224111A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO1999008706A8 (en)	2000-08-10
WO1999008706A1 (en)	1999-02-25
CY1106565T1 (el)	2012-01-25
CN1275084A (zh)	2000-11-29
EP1825863A1 (en)	2007-08-29
AUPO856097A0 (en)	1997-09-04
KR100746524B1 (ko)	2007-08-07
AU2011224111A1 (en)	2011-10-13
DE69837390D1 (de)	2007-05-03
MXPA00001562A (es)	2004-10-14
NZ503039A (en)	2002-09-27
KR20010022882A (ko)	2001-03-26
ID24174A (id)	2000-07-13
ATE357250T1 (de)	2007-04-15
CN100366292C (zh)	2008-02-06
JP2001514871A (ja)	2001-09-18
HK1032755A1 (zh)	2001-08-03
DE69837390T2 (de)	2007-08-23
US7785602B2 (en)	2010-08-31
US7473428B2 (en)	2009-01-06
PT1007088E (pt)	2007-05-31
US7323177B1 (en)	2008-01-29
JP2009213495A (ja)	2009-09-24
JP4365023B2 (ja)	2009-11-18
ES2283068T3 (es)	2007-10-16
EP1007088B1 (en)	2007-03-21
EP1007088A1 (en)	2000-06-14
US20090226485A1 (en)	2009-09-10
EP1007088A4 (en)	2003-01-08
US20060263387A1 (en)	2006-11-23
BR9811184A (pt)	2001-12-26

Publication	Publication Date	Title
ATE357250T1 (de)	2007-04-15	Rekombinanter schweine adenovirus vektor
DE69632235D1 (de)	2004-05-27	Newcastle-Krankheitsvirus-Kombinationsimpfstoff
AU9063801A (en)	2002-03-22	Methods and compositions for diseases associated with amyloidosis
ATE476510T1 (de)	2010-08-15	Schweine-circovirus-impfstoff in rekombinantem pockenvirus
ATE292685T1 (de)	2005-04-15	Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
NO20001768L (no)	2000-06-02	Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
CY1107570T1 (el)	2013-03-13	Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
ATE60799T1 (de)	1991-02-15	Virus-impfstoff.
MXPA02011545A (es)	2003-06-06	Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
IL141623A0 (en)	2002-03-10	Method of dna vaccination
ES2130184T3 (es)	1999-07-01	Polipeptidos y vacunas recombinantes contra el herpesvirus bovino de tipo 1.
DK0439056T3 (da)	1994-08-29	Coccidiose-vacciner
DE69738641D1 (de)	2008-05-29	Lebend-impfstoff gegen heliobacter pylori
BR9508645B1 (pt)	2009-01-13	seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
BR0007855A (pt)	2001-10-23	Vacina de vìrus eliminado o gene bhv-1
GR3029665T3 (en)	1999-06-30	16 kDa SURFACE PROTEIN OF -i(P. FALCIPARUM).
WO1998040497A3 (en)	1998-12-10	An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
PT729509E (pt)	2004-09-30	Vacina contra papeira contendo uma estirpe do virus jerryl-lynn
NZ227943A (en)	1991-08-27	An antigen derived from the neck region of the rhoptries of merozoites and vaccine against plasmodium falciparum
ZA906667B (en)	1991-06-26	Antigens and polypeptides derived from babesia(12d3 antigen)